跳至主要内容
临床试验/CTRI/2018/12/016596
CTRI/2018/12/016596尚未招募1 期

Validation of AIIA Protocol in the management of Diabetic Nephropathy

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diabetic patients having controlled blood glucose level upto FBS 130mg/dl, PPBS 180mg/dl (on medication), Hypertensive patients BP up to 140/90 mm of Hg, Urinary albumin between 30-300mg in 24 Hr. urine sample and GFR between 60-120ml/min/1.73m2

排除标准

  • Uncontrolled diabetic patients if blood glucose level more than FBS 130 mg/dl, PPBS 180 mg/dl, Uncontrolled Hypertensive patients with BP more than 140/90 mm of Hg., Microalbuminuria originating due to other diseases except Diabetes Mellitus.
  • Patients with other severe complications of Diabetes Mellitus, Serum creatinine more than 2.5 mg., Albumin >300mg/day, GFR <60 ml/min.

研究者

相似试验